Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details) - Schedule of option activity

v3.21.1
Stockholders' Equity (Details) - Schedule of option activity - Options [Member]
3 Months Ended
Mar. 31, 2021
USD ($)
$ / shares
shares
Stockholders' Equity (Details) - Schedule of option activity [Line Items]  
Number of Options, Outstanding at beginning | shares 2,430,000
Weighted Average Exercise Price, Outstanding at beginning | $ / shares $ 4.15
Weighted Average Remaining Term (Yrs), Outstanding at beginning 8 years 11 months 1 day
Intrinsic Value, Outstanding at beginning | $
Number of Options, Exercisable | shares 557,500
Weighted Average Exercise Price, Exercisable | $ / shares $ 4.33
Weighted Average Remaining Term (Yrs), Exercisable 8 years 7 months 13 days
Intrinsic Value, Exercisable | $
Number of Options, Granted | shares
Weighted Average Exercise Price, Granted | $ / shares
Number of Options, Exercised | shares
Weighted Average Exercise Price, Exercised | $ / shares
Number of Options, Expired | shares
Weighted Average Exercise Price, Expired | $ / shares
Number of Options, Forfeited | shares
Weighted Average Exercise Price, Forfeited | $ / shares
Number of Options, Outstanding at ending | shares 2,430,000
Weighted Average Exercise Price, Outstanding at ending | $ / shares $ 4.15
Weighted Average Remaining Term (Yrs), Outstanding at ending 8 years 8 months 1 day
Intrinsic Value, Outstanding at ending | $ $ 146,800